Art
J-GLOBAL ID:201902290081053940   Reference number:19A1034393

Impact of molecular response of Nilotinib for BCR/ABL1 transcripts >10% with Imatinib 3 and/or 6 months by Sokal risk in chronic phase chronic myelogenous leukemia

慢性期慢性骨髄性白血病におけるSokaiリスクによるイマチニブ3か月および/または6か月でのBCR/ABL1転写産物>10%に対するニロチニブの分子反応の影響
Author (2):
Material:
Volume: 56th  Page: ROMBUNNO.FP3-19 (WEB ONLY)  Publication year: 2018 
JST Material Number: U0695A  Document type: Proceedings
Article type: 会議録記事  Country of issue: Japan (JPN)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A1034393&from=J-GLOBAL&jstjournalNo=U0695A") }}
JST classification (3):
JST classification
Category name(code) classified by JST.
Blood cell tumors(=neoplasms)  ,  Drug therapy(=pharmacotherapy)for tumors  ,  Clinical application of other drugs 
Substance index (2):
Substance index
Chemical Substance indexed to the Article.

Return to Previous Page